AllianceBernstein
KYTH

AllianceBernstein’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

AllianceBernstein’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-43,870
Closed -$3.29M – 3006
2015
Q3 		$3.29M Sell
43,870
-728,390
-94% -$54.4M ﹤0.01% 1281
2015
Q2 		$58.2M Buy
772,260
+43,556
+6% +$2.33M 0.05% 431
2015
Q1 		$36.5M Buy
728,704
+300,010
+70% +$12.6M 0.03% 554
2014
Q4 		$14.9M Sell
428,694
-50,617
-11% -$1.77M 0.01% 789
2014
Q3 		$15.7M Sell
479,311
-17,468
-4% -$615K 0.01% 759
2014
Q2 		$19.1M Sell
496,779
-15,259
-3% -$533K 0.02% 713
2014
Q1 		$20.4M Buy
512,038
+15,270
+3% +$683K 0.02% 676
2013
Q4 		$18.5M Buy
496,768
+459,866
+1,246% +$19.1M 0.02% 685
2013
Q3 		$1.69M Buy
36,902
+31,326
+562% +$937K ﹤0.01% 1806
2013
Q2 		$151K Buy
+5,576
New +$128K ﹤0.01% 2900

AllianceBernstein's KYTH Position: Q4 2015 in Review

AllianceBernstein sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 43,870 shares — an estimated $3.29M sold.

AllianceBernstein first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $58.2M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • AllianceBernstein reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • AllianceBernstein sold 43,870 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $3.29M.
  • AllianceBernstein first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • AllianceBernstein's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $58.2M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on AllianceBernstein's 13F filing for Q4 2015, filed 12 Feb 2016.